Telomir Pharmaceuticals logo
Telomir Pharmaceuticals
TELO | NASDAQ
Chart Builder DCF Calculator
$0.49
-$0.01 (-2.08%)
At close: Nov 13, 2026, 4:00 PM ET
$0.50
+$0.01 (+2.45%)
After-hours: Nov 13, 2026, 7:30 PM ET

Telomir Pharmaceuticals Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
-10.41M -16.53M -13.07M -854.15K -138.13K
– 4.34M – 854.15K 138.13K
5.29M 6.87M – – –
645.46K -57.16K -713 385.49K 18.74K
840K 130K 9.1M -854.15K -138.13K
– – – – –
594.69K 126.47K 113.84K 385.49K 18.74K
-3.69M -5.07M -3.86M -468.66K -119.4K
– – -4 – –
– – – – –
– – – – –
– – – – –
– – – – –
– – – – –
– -101K 3.17M 462.39K –
– – – – –
– – – – –
155.52K -396.65K -310.38K 7.69K 119.4K
9.71M 6.34M 3.86M 470.08K 119.4K
6.02M 1.26M -188 1.42K –
-3.69M -5.07M -3.86M -468.66K -119.4K
-8.98M -11.94M -3.86M -468.66K -119.4K
– – – – –
– – -4 – –
-3.69M -5.07M -3.86M -468.66K -119.4K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.